Skip to content
Visit Recipharm.com

xRNA Manufacturing

End-to-End xRNA Production for Advanced Therapies

xRNA-based therapies—including mRNA vaccines, therapeutic mRNA, self-amplifying RNA, and circular RNA—are transforming the landscape of medicine. Bringing these therapies to patients requires a manufacturing partner with deep expertise, integrated capabilities, and a commitment to innovation.

ReciBioPharm provides an advanced xRNA manufacturing platform, offering a seamless process from template design through final drug product. With comprehensive in-house expertise and a next-generation continuous RNA manufacturing platform, we deliver scalable, high-quality solutions tailored to the needs of emerging and established RNA modalities.

Schedule Virtual Tour

Industry-Leading Continuous xRNA Manufacturing

With grant support from the FDA’s Center for Biologics Evaluation and Research (CBER) Advanced Technology Program and in collaboration with MIT, Recipharm Advanced Bio has pioneered a groundbreaking continuous xRNA manufacturing platform.

Sequence to final product in less than 4 months

xRNA Manufacturing Resources

Advancing Your Program Together

Your program isn’t just another project—it’s a breakthrough in the making. At Recipharm Advanced Bio, we bring deep scientific expertise, innovative thinking, and a problem-solving mindset to every partnership. Whether scaling a complex process, navigating regulatory pathways, or optimizing for commercial success, we’re here to collaborate, adapt, and deliver with excellence.

Let’s push the boundaries of possibility together and bring transformative therapies to patients faster.

Contact Us